Bright, R. K. Preclinical support for tumor protein D52 as a cancer vaccine antigen. Taylor & Francis Group.
Chicago Style (17th ed.) CitationBright, Robert K. Preclinical Support for Tumor Protein D52 as a Cancer Vaccine Antigen. Taylor & Francis Group.
MLA (9th ed.) CitationBright, Robert K. Preclinical Support for Tumor Protein D52 as a Cancer Vaccine Antigen. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.